Medicinova (MNOV) Operating Expenses (2010 - 2026)
Medicinova (MNOV) posted quarterly Operating Expenses of $3.2 million for Q4 2025, up 1.9% year-over-year from $3.2 million in Q4 2024, and down 7.42% quarter-over-quarter from $3.5 million in Q3 2025.
Medicinova (MNOV) Operating Expenses (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Operating Expenses for 16 consecutive years, with $3.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Expenses rose 1.9% year-over-year to $3.2 million; the TTM figure through Dec 2025 stood at $13.7 million (up 8.03% YoY), while the FY2025 annual figure was $13.7 million, up 8.03% from the prior year.
- Operating Expenses eased to $3.2 million in Q4 2025 per MNOV's latest filing, from $3.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $4.3 million in Q2 2021 and bottomed at $2.1 million in Q4 2021.
- Historically, Operating Expenses has averaged $3.3 million across 5 years, with a median of $3.3 million in 2023.
- Annual changes were most pronounced in 2023 — Operating Expenses slumped 44.92% — and 2024, when it jumped 54.14%.
- Medicinova's Operating Expenses stood at $2.1 million in 2021, then jumped by 53.66% to $3.2 million in 2022, then fell by 22.94% to $2.5 million in 2023, then advanced by 27.85% to $3.2 million in 2024, then grew by 1.9% to $3.2 million in 2025.
- Business Quant data shows MNOV's Operating Expenses at $3.2 million in Q4 2025, $3.5 million in Q3 2025, and $3.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 541.02 Mn |
| 10 | Medicinova | 68.91 Mn | 68.91 Mn | 317,759.00 | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Dec 31, 2025 | 3.24 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 3.20 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Dec 31, 2023 | 2.49 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 2.96 Mn |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 3.90 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 3.64 Mn |
| Jun 30, 2021 | 4.31 Mn |